An Integrative Pan-Cancer Analysis of PBK in Human Tumors
Background: PDZ binding kinase (PBK) is a serine/threonine kinase, which belongs to the mitogen-activated protein kinase kinase (MAPKK) family. It has been shown to be a critical gene in the regulation of mitosis and tumorigenesis, but the role of PBK in various cancers remains unclear. In this stud...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/07eb1fecbc8f4a0f928234d9b270337a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:07eb1fecbc8f4a0f928234d9b270337a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:07eb1fecbc8f4a0f928234d9b270337a2021-11-10T07:31:41ZAn Integrative Pan-Cancer Analysis of PBK in Human Tumors2296-889X10.3389/fmolb.2021.755911https://doaj.org/article/07eb1fecbc8f4a0f928234d9b270337a2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmolb.2021.755911/fullhttps://doaj.org/toc/2296-889XBackground: PDZ binding kinase (PBK) is a serine/threonine kinase, which belongs to the mitogen-activated protein kinase kinase (MAPKK) family. It has been shown to be a critical gene in the regulation of mitosis and tumorigenesis, but the role of PBK in various cancers remains unclear. In this study, we systematically explored the prognostic and predictive value of PBK expression in 33 cancer types.Methods: Public databases including the cBioPortal database, GDSC database, GTEx database, CCLE database, and TCGA database were used to detect the PBK expression and its association with the prognosis, clinicopathologic stage, TMB, MSI, immune microenvironment, immune checkpoints, immune cell infiltration, enrichment pathways, and IC50 across pan-cancer. The statistical analyses and visualization were conducted using R software.Results: PBK expression is relatively high in most cancers compared to their normal counterparts, and this gene is barely expressed in normal tissues. High expression of PBK is significantly associated with poor prognosis and clinicopathologic stages I, II, and III in different cancers. Furthermore, PBK expression is strongly associated with TMB in 23 cancer types and associated with MSI in nine cancer types. Moreover, the correlation analysis of the microenvironment and immune cells indicated that PBK is negatively correlated with the immune infiltration levels but positively correlated with the infiltration levels of M0 and M1 macrophages, T cells CD4 memory activated, and T cells follicular helper. GSEA analysis revealed that the biological function or pathways relevant to the cell cycle and mitosis were frequently enriched at the level of high expression of PBK.Conclusion: These results revealed the oncogenic role of PBK, which is significantly upregulated in various cancers and indicated poor prognosis and immune infiltration in multiple cancers. It also suggested that PBK may serve as a biomarker in multiple tumor progress and patient survival.Huantao WenZitao ChenMin LiQiongzhen HuangYuhao DengJiawei ZhengMoliang XiongPengfei WangWangming ZhangFrontiers Media S.A.articlepan-cancerPBKbiomarkertumor cell proliferationprognosisBiology (General)QH301-705.5ENFrontiers in Molecular Biosciences, Vol 8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
pan-cancer PBK biomarker tumor cell proliferation prognosis Biology (General) QH301-705.5 |
spellingShingle |
pan-cancer PBK biomarker tumor cell proliferation prognosis Biology (General) QH301-705.5 Huantao Wen Zitao Chen Min Li Qiongzhen Huang Yuhao Deng Jiawei Zheng Moliang Xiong Pengfei Wang Wangming Zhang An Integrative Pan-Cancer Analysis of PBK in Human Tumors |
description |
Background: PDZ binding kinase (PBK) is a serine/threonine kinase, which belongs to the mitogen-activated protein kinase kinase (MAPKK) family. It has been shown to be a critical gene in the regulation of mitosis and tumorigenesis, but the role of PBK in various cancers remains unclear. In this study, we systematically explored the prognostic and predictive value of PBK expression in 33 cancer types.Methods: Public databases including the cBioPortal database, GDSC database, GTEx database, CCLE database, and TCGA database were used to detect the PBK expression and its association with the prognosis, clinicopathologic stage, TMB, MSI, immune microenvironment, immune checkpoints, immune cell infiltration, enrichment pathways, and IC50 across pan-cancer. The statistical analyses and visualization were conducted using R software.Results: PBK expression is relatively high in most cancers compared to their normal counterparts, and this gene is barely expressed in normal tissues. High expression of PBK is significantly associated with poor prognosis and clinicopathologic stages I, II, and III in different cancers. Furthermore, PBK expression is strongly associated with TMB in 23 cancer types and associated with MSI in nine cancer types. Moreover, the correlation analysis of the microenvironment and immune cells indicated that PBK is negatively correlated with the immune infiltration levels but positively correlated with the infiltration levels of M0 and M1 macrophages, T cells CD4 memory activated, and T cells follicular helper. GSEA analysis revealed that the biological function or pathways relevant to the cell cycle and mitosis were frequently enriched at the level of high expression of PBK.Conclusion: These results revealed the oncogenic role of PBK, which is significantly upregulated in various cancers and indicated poor prognosis and immune infiltration in multiple cancers. It also suggested that PBK may serve as a biomarker in multiple tumor progress and patient survival. |
format |
article |
author |
Huantao Wen Zitao Chen Min Li Qiongzhen Huang Yuhao Deng Jiawei Zheng Moliang Xiong Pengfei Wang Wangming Zhang |
author_facet |
Huantao Wen Zitao Chen Min Li Qiongzhen Huang Yuhao Deng Jiawei Zheng Moliang Xiong Pengfei Wang Wangming Zhang |
author_sort |
Huantao Wen |
title |
An Integrative Pan-Cancer Analysis of PBK in Human Tumors |
title_short |
An Integrative Pan-Cancer Analysis of PBK in Human Tumors |
title_full |
An Integrative Pan-Cancer Analysis of PBK in Human Tumors |
title_fullStr |
An Integrative Pan-Cancer Analysis of PBK in Human Tumors |
title_full_unstemmed |
An Integrative Pan-Cancer Analysis of PBK in Human Tumors |
title_sort |
integrative pan-cancer analysis of pbk in human tumors |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/07eb1fecbc8f4a0f928234d9b270337a |
work_keys_str_mv |
AT huantaowen anintegrativepancanceranalysisofpbkinhumantumors AT zitaochen anintegrativepancanceranalysisofpbkinhumantumors AT minli anintegrativepancanceranalysisofpbkinhumantumors AT qiongzhenhuang anintegrativepancanceranalysisofpbkinhumantumors AT yuhaodeng anintegrativepancanceranalysisofpbkinhumantumors AT jiaweizheng anintegrativepancanceranalysisofpbkinhumantumors AT moliangxiong anintegrativepancanceranalysisofpbkinhumantumors AT pengfeiwang anintegrativepancanceranalysisofpbkinhumantumors AT wangmingzhang anintegrativepancanceranalysisofpbkinhumantumors AT huantaowen integrativepancanceranalysisofpbkinhumantumors AT zitaochen integrativepancanceranalysisofpbkinhumantumors AT minli integrativepancanceranalysisofpbkinhumantumors AT qiongzhenhuang integrativepancanceranalysisofpbkinhumantumors AT yuhaodeng integrativepancanceranalysisofpbkinhumantumors AT jiaweizheng integrativepancanceranalysisofpbkinhumantumors AT moliangxiong integrativepancanceranalysisofpbkinhumantumors AT pengfeiwang integrativepancanceranalysisofpbkinhumantumors AT wangmingzhang integrativepancanceranalysisofpbkinhumantumors |
_version_ |
1718440437990031360 |